pharma News

Enormous technological leaps have changed almost every aspect of the modern lives we lead and how our jobs are done.

With declining R&D costs, prioritizing a portfolio of successful projects has become essential within the pharmaceutical industry.

New Report on The PI3K/Akt/mTor Pathway authored by, Peter Norman, MBA, PhD

Healthcare is in crisis throughout the world, but an innovative forum will seek solutions by connecting health, biotech and pharmaceutical CEOs and other senior executives with institutional investors and business development executives.

Webchutney announces launch of its digital healthcare report in India.

Globaldata’s” M&A Activity In The Unconventional Oil & Gas Segment - Q3 2011 ” is now available at ReportsnReports.com.

Pharmacists perceive themselves as having a strong say in patients’ purchase decisions

Biotech patent circles are buzzing over the opportunity to engage USPTO patent examiners in an exclusive session at the American Conference Institute’s 13th Advanced Forum on Biotech Patents later this month in Boston.

Visiongain predicts that the antibody therapeutics sector will be revitalised by the approval of next-generation products this decade. Overall next-generation therapeutic antibody revenues will reach $2.3bn in 2015.

Andrew Miller Meets Technicians Of The Future At Britain's Largest Independent Calibration and Maintenance Company

Bart Bierman M.D, who has 25+ Years experience within the pharmaceutical industry discusses what is required to be a successful interim.

Visiongain predicts that small-molecule targeted cancer therapy revenues will reach $27.3bn worldwide in 2015. That overall market generated $20.3bn in 2010, according to Small-Molecule Targeted Cancer Therapies: World Market 2011-2021.

Cost and productivity benefits ensure greater traction for CRO services

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

Eric Ruhlmann, European Patent Attorney Director, Senior Patent Counsel, Legal Department, Actelion Pharmaceuticals Ltd, joins Pharma IQ, to discuss the latest challenges for patenting pharmaceutical inventions and trends in global patent law

Enormous technological leaps have changed almost every aspect of the modern lives we lead and how our jobs are done.

The pharmaceutical industry's 'cold chain', the controlled route along which temperature-sensitive products are distributed, plays a critical role in ensuring the shelf life and integrity of medicines and biologics.

Mumbai – (October 24, 2011) – Ajanta Pharma Limited, a specialty focused pharmaceutical formulation company, has posted 18% increase in net profit for the second quarter of FY 2011-12.

mHealth Alliance's leader,the group founded by UN Foundation will speak at mHealthcon Mobile Health Conference Dec.1st. Exclusively dedicated to the mobile health apps market, it will feature C-level speakers, exhibits workshops and product demos.

20 October 2011. London. UK. A new report by visiongain, a London-based business information company, predicts that world revenues for epigenetic therapies and technologies will reach $2.73bn in 2015.

Hear directly from GSK and other pharmaceutical companies on how they are developing their social media strategy at...

As technology advances, software design plays an increasingly critical role in a growing number of healthcare divisions.

Just Published Report on Cytokine-Based Therapies and Inhibitors: R&D Pipelines, Markets, and Strategic Issues

The world's leading pharmaceutical companies are currently staring in the face of extremely challenging times, as a raft of patents for blockbuster drugs are poised to expire over the coming five years.

A crucial consideration in any pharmaceutical manufacturing process, and particularly when work involves biological elements, is how to mitigate the risk of contamination.

Visiongain predicts that the global neuromodulation devices market will be worth $11.61bn by 2021. The market generated sales of $2.70bn in 2010, according to Neuromodulation Devices: World Market Prospects 2011-2021, published in October 2011.

As the regulatory landscape becomes increasingly complex, pharmaceutical packagers are turning in their droves towards serialisation as they strive for compliance with the 2015 ePedigree deadline,

A new report by visiongain, a London-based business information company, predicts that worldwide pharma contract sales revenues will reach $5.24bn in 2015. In particular, non-personal promotional services will stimulate market growth.

Experts from HAAD to give latest updates on safety of OTC products at Abu Dhabi Medical Congress

The unmet need for a convenient and safe rheumatoid arthritis (RA) treatment option without adverse side effects has set the stage for a spate of drug launches in the near future.

Visiongain predicts that the market for Parkinson's disease drugs will reach $3754m in 2015. This decade, new products, including adenosine receptor antagonists, will benefit the Parkinson's treatment market and stimulate growth of overall revenue.

The three-day India – Latin America and the Caribbean (LAC) Pharma Business Meet being organized by Pharmaceuticals Export Promotion Council (Pharmexcil) gets underway in the city from Tuesday, September 27, 2011.

View IPR’s Most Recent Report Titles from the 2011 Catalog and Our Newly Launched Insight Update Series.

Conducting 100s of research studies with various pharmaceutical companies, each day, research uncovers new vital, information. ETCCR's goal is to provide a quality service while advancing medical technology.

Within the next five years, the global biologics market is set to exceed $239 billion (£145 billion) in value, according to recent research by Bharat Book.

With healthcare's growing emphasis on the comparative effectiveness of new drugs in relation to what is already available, recent times have brought forth an expectation for developers to prove additional benefits at the clinical trial stage.

REMCON Plastics develops a custom designed hopper cradle assembly with the precision to work in an automated guided vehicle storage system

A new report by Visiongain predicts that overall revenues for monoclonal antibody (mAb) therapies will rise between 2011 and 2021. The world mAb drugs market will reach $62.3bn in 2015, up from revenues of $44.6bn (USD) in 2010.

Visiongain predicts the global market for interventional cardiology devices to be worth $25.5bn by 2021. The market generated $9.8bn in 2010 according to Interventional Cardiology Devices: World Market Prospects 2011-2021, published in September.

Conference unites industry peers to strengthen forecasting strategies and improve performance in emerging markets

This event will bring together senior scientists, medical directors, Biostatisticians to address and find solutions to current issues in biomarker efficiency and strategies

Greiner Bio One is proud to announce that due to the high international demand of our webinar series in 2011, all webinars will be available in English and German versions.

Navigating the regulatory highway: what might regulatrory guidance mean for the Industry?

A webinar with industry experts Nik Zeps of St John of God Pathology, Australia, and Ruth Chadwick of Cesagen, Cardiff University, UK

Two thought-leaders and experts on phase II clinical trials will be the keynote speakers at the CHI’s Accelerating Proof of Concept: Clinical Success Driven by Science & Strategy, set for October 3-5 at the Crowne Plaza Hotel in Philadelphia, PA.

Clinical development is expensive, invariably high risk and at times enormously inefficient, which is most likely the reason why productivity is sliding so rapidly in the pharmaceutical industry.

Ever-increasing demand for personalised medicine has enhanced the global requirement for biobanks to provide human tissue, body fluids and their derivatives.

Insight Pharma Reports Announces Next-Generation Mass Spectrometry: Technology Advances and Applications, Authored by K. John Morrow, Jr., PhD.

Engineering Next-Generation Therapeutic Proteins: Trends and Markets To 2020 Report

Exelsius, the international cold chain management consultancy, is proud to announce that it has teamed up with IQPC to deliver a 2-­‐day training course.